Safe Prescribing of Antibiotics in Dental Practice

Abstract

Rational antibiotic use in dental practice is imperative to curb the global rise of antimicrobial resistance and ensure optimal patient outcomes. Dentists are among the leading prescribers of antibiotics in community healthcare, and inappropriate or unnecessary antibiotic prescriptions have significant public health implications. This review critically analyzes the current evidence, pathophysiology, risk factors, clinical features, diagnostic criteria, and management strategies pertaining to antibiotic use in dentistry. The article synthesizes international guideline recommendations, recent advances, and practical considerations to support safe, evidence-based antibiotic prescribing for dental practitioners and allied healthcare professionals.

Introduction

The increasing prevalence of antimicrobial resistance (AMR) is a major global health concern, with the World Health Organization (WHO) highlighting inappropriate antibiotic prescribing as a key driver. Dental practitioners contribute significantly to community antibiotic use, with studies indicating up to 10% of all outpatient antibiotic prescriptions originate in dentistry. The clinical challenge lies in distinguishing cases where antibiotics are genuinely indicated from those amenable to local dental intervention alone. Inappropriate prescribing not only propagates resistant strains but also exposes patients to adverse drug reactions and Clostridioides difficile infection. Therefore, a thorough understanding of the principles of safe antibiotic prescribing is essential for the dental team.

Epidemiology / Disease Burden

Dental infections, including odontogenic infections, periapical abscesses, and periodontal disease, are common reasons for antibiotic prescriptions. Epidemiological data indicate marked geographical variation in prescribing patterns, with higher rates observed in certain regions where guideline adherence is suboptimal. In the UK, for example, dental antibiotic prescriptions account for approximately 7% of all community antibiotic use. In the US and Europe, concerns have been raised about the proportion of dental prescriptions that are unnecessary or not aligned with current guidelines, particularly for conditions such as irreversible pulpitis or localized dental pain absent of systemic involvement.

Pathophysiology

Odontogenic infections are primarily polymicrobial, involving anaerobic and facultative anaerobic bacteria. The pathogenic process typically begins with pulpal or periodontal tissue invasion, leading to localized infection that can extend to deeper fascial spaces if untreated. Bacterial species such as Streptococcus anginosus, Prevotella, and Fusobacterium are commonly implicated. The host immune response, tissue vascularity, and presence of necrotic or hypoxic environments influence both the progression of infection and the efficacy of antibiotic therapy. Understanding the microbiological landscape is crucial for selecting the most appropriate antibiotic when systemic therapy is indicated.

Risk Factors

Several patient- and procedure-related factors increase the risk of dental infection and the need for systemic antibiotics. Immunocompromised states, including diabetes mellitus, malignancy, HIV infection, and use of immunosuppressive drugs, heighten susceptibility to severe odontogenic infections. Other risk factors include poor oral hygiene, pre-existing periodontal disease, recent dental procedures (especially in high-risk individuals), and failure of local measures to control infection. Identification of these risk factors should guide the clinician in making evidence-based prescribing decisions.

Clinical Features

Odontogenic infections may present with localized pain, swelling, erythema, and purulence. Systemic involvement, characterized by fever, malaise, dysphagia, trismus, or lymphadenopathy, signals a higher risk of spreading infection and is an indication for antibiotic therapy. Severe cases can progress to cellulitis, Ludwig's angina, or deep neck space infections, necessitating urgent intervention. It is vital to differentiate between localized, self-limiting infections and those with systemic manifestations requiring antibiotics.

Diagnosis

Diagnosis is based on thorough clinical assessment, supported by radiographic imaging where indicated. Signs of spreading infection, systemic toxicity, or failure to respond to local measures (such as drainage or extraction) warrant consideration of systemic antibiotics. Microbiological sampling is generally reserved for non-responsive or atypical infections. Diagnosis should be prompt to avoid complications, but unnecessary antibiotic use should be scrupulously avoided by relying on established diagnostic criteria.

Treatment & Management

The cornerstone of odontogenic infection management is removal of the source through definitive dental treatment (e.g., drainage, extraction, endodontic therapy). Antibiotics are adjunctive, reserved for cases with systemic involvement, spreading infection, or high-risk patients. First-line agents typically include penicillins (e.g., amoxicillin), with alternatives such as clindamycin for penicillin-allergic patients. Treatment should be guided by the narrowest spectrum agent effective for likely pathogens, prescribed at the appropriate dose and shortest effective duration (usually 3–5 days). Patient education on adherence and adverse effects is vital to minimize risks.

Recent Advances / Emerging Therapies

Recent advances include the development of more precise diagnostic tools, such as point-of-care bacterial identification and rapid susceptibility testing. There is growing interest in host-modulating therapies and the use of adjunctive measures (e.g., photodynamic therapy, probiotics) to reduce antibiotic reliance. Stewardship programs, electronic prescribing audits, and feedback interventions have demonstrated efficacy in reducing inappropriate dental antibiotic prescriptions, promoting adherence to evidence-based guidelines.

Guideline Recommendations

International guidelines, including those from the American Dental Association (ADA), UK Faculty of General Dental Practice (FGDP), and National Institute for Health and Care Excellence (NICE), emphasize that antibiotics should not be used as a substitute for definitive dental treatment. Antibiotics are recommended only for cases with signs of systemic involvement, spreading infection, or for immunocompromised patients. Clear documentation of indications, agent selection, dosing, and duration is critical. Routine prophylactic antibiotics for dental procedures are no longer recommended except in select high-risk cardiac conditions or immunocompromised states, per updated consensus statements.

Conclusion

Safe and rational antibiotic prescribing in dental practice is a crucial component of antimicrobial stewardship and patient safety. Clinical decision-making should be grounded in current evidence, guideline recommendations, and patient-specific risk assessment. Effective communication with patients and interdisciplinary collaboration are essential to minimize unnecessary antibiotic exposure and curb the rise of antimicrobial resistance. Ongoing education, stewardship initiatives, and adoption of emerging diagnostic technologies will further enhance the quality of care in dental settings.